BSECompany Update30 Sept 2026 · 30 Sept 2026, 06:29 pm

Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations, 2015, we would like to inform you that the Company has received approval of its members by Special Resolution passed in the 41st AGM of the Company held on September 30, 2026 for appointment of Mr. Dipankar Dasgupta as Independent Non-Executive Director of the Company with effect from October 01, 2026 in place of retiring Independent Non Executive Director Mr. ....

Gennex Laboratories Ltd · 531739

✦ AI SummaryMgmt Change

Gennex Laboratories Ltd has announced the appointment of Mr. Dipankar Dasgupta as an Independent Non-Executive Director, replacing Mr. Amudala Sreeramulu Nageswar Rao, with effect from October 1, 2026.

Analysis Scores

Earnings Impact2/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Gennex Laboratories Ltd - 531739 - Announcement under Regulation 30 (LODR)-Change in Management

Attachments (1)

📄

2768e790-3d52-451f-963a-3beefb45258a.pdf

pdf

Download →
View document text
CG GENNEX LABORATORIES LIMITED Ref: GLL/BSE/2026-27/Sep- ————y—ou can ty te: September 30, 2026 To To The General Manager, The Listing Manager, Corporate Relations Department, The Ahmedabad Stock Exchange Limited BSE Limited A-2, Kamdhenu Complex, Opp. Sahajanand Phiroze Jeejecbhoy Towers, College, 120 Feet Ring Road, Panjara Pol, Dalal Street, Mumbai — 400001. Ambawadi, Ahmedabad - 380015. Maharashtra State, India. Gujarat State, India. Script Code: 531739 Script Code: The Calcutta Stock Exchange Limited, #7, Lyons Range, Murgighata, Dalhousie, Kolkata - 700001, West Bengal State, India. Scrip Code: 26178 Sub: Appointment and Retirement of Independent (Non-Executive) Directors of the Company Ref: Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 Dear Sir/Madam, Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 ("Listing Regulations"), we would like to inform you that the Company has received approval of its members by Special Resolution passed in the 41* Annual General Meeting of the Company held on September 30, 2026 for appointment of Mr. DIPANKAR DASGUPTA (DIN: 05312364) as Independent (Non- Executive) Director of the Company with effect from October 01, 2026 in place of retiring Independent (Non-Executive) Director, Mr. AMUDALA SREERAMULU NAGESWAR RAO (DIN: 07030259) whose current period of office has expired on the date of AGM i.e. September 30, 2026. Mr. DIPANKAR DASGUPTA will be a Non-Executive & Independent Director and he is not related to the Promoter or Promoter Group and fulfils the criteria as required under the provisions of the Companies Act, 2013 and the Rules framed thereunder and the Listing Regulations. The relevant details of the captioned appointment and retirement, as per the requirements of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular #SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, are given in the enclosed Annexure A along with disclosure in Form B under the SEBI (Prohibition of Insider Trading) Regulations, 2015. We request you to take note of the above information on record and acknowledge the receipt of the same. Thanking you, Yours faithfully, For Gennex Laboratories Limited Bra aD) raat Dine Kutna? Kpiriya \O\ Company Secretary & Compliance Officer Gennex Laboratories Limited Akash Ganga, 4th Floor, Plot No.144, Srinagar Colony, Hyderabad-500073, Telangana Stale, India | Tel : +91-40-67334400 (30 Lines), 23746451 Factory : Sy.No.133, Bollaram Village, Jinnaram Mandal, Sangareddy Dist - 502 325, Telangana State, India. Tel : +91-08458 295516, info@gennexlab.com, www.gennexlab.com | CIN : L24230TG1990PLC011168 YEE € GcNNex LABORATORIES LIMITED ——-———YsEU con rust Annexure A Disclosures as per the Listing Regulations and SEBI Circular no. SEBI/HO/CFD/CFD- PoD-1/P/CIR/2023/123 dated July 13, 2023: A. APPOINTMENT OF INDEPENDENT DIRECTORS: Particulars Details Mr. DIPANKAR DASGUPTA __ Name of the Director Reasons for Change Appointment | Date of Appointment October 01, 2026 Term of Appointment Independent (Non-Executive) Director B.Com.; CA (Inter) Mr. Dasgupta has more than 35 years of experience in the finance, economy and Brief Profile management, the proficient English speaker on the current economic and financial affairs and having extensive command on the various foreign _languages including English. _ Relationship Inter-se Directors / Key Not related to any Directors/ Key Managerial Managerial Personnel Personnel of the Company. Information as required under Circular Mr. DIPANKAR DASGUPTA is not debarred from No. NSE/CML/2018102 dated June holding office of a director by virtue of any SEBI 20, 2018 issued by NSE _ order or any other such authority B. RETIREMENTS OF INDEPENDENT DIRECTORS: # Particulars Description 1. | Name of the Director Mr. Amudala Sreeramulu Nageswar Rao | Mr. Amudala Sreeramulu Nageswar Rao (DIN: | 9 Reason for Change: 07030259) ceases to be an Independent | | (Retirement) Director of the Company upon completion of his first term as an Independent Director. Date of . | 3. A . /Cessation SS e» pteY mbearr G3 0, 2 2022 6 - 4. | Term Of Appointment N.A. 5. Brief Profile (in case of NA. appointment) Disclosure of relationship 6. | between Directors (in case of | N.A. appointment of a Director) For ve Limited Dinesh Kumanr ae Company Secretary & Compliance Officer Membership No. A/ 19293 Gennex Laboratories Limited Akash Ganga, 4th Floor, Plot No.144, Srinagar Colony, Hyderabad-500073, Telangana State, India | Tel : +91-40-67334400 (30 Liries), 23746451 Factory : Sy,No.133, Bollaram Village, Jinnaram Mandal, Sangareddy Dist - 502 325, Telangana State, India. Tel : +91-08458 295516, info@gennexlab.com, www.gennexlab.com 4 GIN ; L24230TG1990PLC011168 FORM B SEBI (Prohibition of Insider Trading) Regulations, 2015 [Regulation 7 (1) (b) read with Regulation 6(2) — Disclosure on becoming a Key Managerial Personnel/Director/Promoter/Member of the promoter group] Name of the Company: Gennex Laboratories Limited ISIN of the Company: INESO9C0 1026 Details of Securities held on appointment of Key Managerial Personnel (KMP) or Director or upon becoming a Promoter or member of the promoter group of a listed company and immediate relatives of such persons and by other such persons as mentioned in Regulation 6(2). Name, PAN, CIN/ DIN& Category of Date of Securities held at the time of % of Address with contact nos. Person (KMP | appointment appointment of KMP/ Director or Shareho /Director or of KMP/ upon becoming Promoter or lding Promoter or Director/OR member of the promoter group member of Date of Type of securities (For e.g.- No the promoter | becoming Shares, Warrants, group/Imme | Promoter/me | Convertible Debentures, diate relative | mber of the Right entitlements, etc.) to/others, promoter etc) group 1 2 3 4 5 6 Name: Dipankar Dasgupta | Director 01.10.2026 NIL NIL | NIL PAN: BEKPD9415D DIN: 05312364 Address: 289A, Banerjee Para Road, Chatterjee Bagan, West Putiary, Kolkata - 700041. Email:dgdipankarca@yahoo Contact No.: +91- 8697919168 Note: “Securities” shall have the meaning as defined under regulation 2(1)() of SEBI (Prohibition of Insider Trading) Regulations, 2015. Details of Open Interest (OJ) in derivatives on the securities of the company held on appointment of KMP or Director or upon becoming a Promoter or member of the promoter group of a listed company and immediate relatives of such persons and by other such persons as mentioned in Regulation 6(2). Open Interest of the Future contracts held at the time Open Interest of the Option Contracts held at the time of appointment of Director/KMP or upon becoming of appointment of Director/KMP or upon becoming Promoter/member of the promoter group Promoter/member of the promoter group Contract Number of | Notional value | Contract Number of | Notional value specifications units (contracts | in Rupee terms | specifications units (contracts | in Rupee terms lot size) * lot size) 7 8 9 10 11 12 Note: In case of Options, notional value shall be calculated based on premium plus strike price of options. Dipankar Das Digitally signed by Dipankar Das Gupta Gupta Date: 2026.09.30 13:57:35 +05'30' Name & Signature: Dipankar Dasgupta DIN #: 05312364 Date: September 30, 2026 Place: Kolkata